{
    "clinical_study": {
        "@rank": "3025", 
        "arm_group": [
            {
                "arm_group_label": "Salbutamol 2,5 mg", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Salbutamol 5mg", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Ipratropium 0.5", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients of the ICU's often require bronchodialtatory treatment due to bronchospazm caused\n      by conditions like : ARDS, COPD or asthma. The \u03b22 adreneregic drugs are one of the most\n      commonly used for this purpose. However it is known that they may cause tachycardia and may\n      have substantial proarrhythmic effect. The investigators' aim is to estimate the influence\n      of nebulized bronchodilatatory drugs on selected electrophysiological parameters, whose\n      changes are generally recognized as potentially increasing the risk of ventricular and\n      supraventricular arrhythmias. Two drugs will be compared - salbutamol given in two doses and\n      ipratropium bromide"
        }, 
        "brief_title": "Nebulized Bronchodilatators and Cardiac Repolarization", 
        "condition": [
            "Influence of Nebulized Bronchodilatators on Selected", 
            "Electrophysiological Parameters"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  the necessity of b2 adrenergics an m2 mimetics administration\n\n        Exclusion Criteria:\n\n          -  patients with past  medical history of ventricular arrhythmias ( ventricular\n             tachycardia, ventricular fibril, Torsade de pointes)\n\n          -  patients with persistent atrial fibrillation\n\n          -  patients with abnormal plasma sodium, potassium, magnesium, and ionized calcium\n             concentration"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01714401", 
            "org_study_id": "TJ-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Salbutamol 2,5 mg", 
                "description": "20 min nebulization of 2.5 mg of salbutamol", 
                "intervention_name": "ventolin 2.5mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Salbutamol 5mg", 
                "description": "20 min nebulization of 5 mg of salbutamol", 
                "intervention_name": "Ventolin 5mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ipratropium 0.5", 
                "description": "20 min nebulization of 0.5 mg of ipratropium bromide", 
                "intervention_name": "Atrovent 0.5mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Albuterol", 
                "Ipratropium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 24, 2012", 
        "location": [
            {
                "contact": {
                    "email": "tjasinski@uck.gda.pl", 
                    "last_name": "Tomasz Jasinski, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gdansk", 
                        "country": "Poland", 
                        "zip": "80-214"
                    }, 
                    "name": "Medical University of Gdansk - Departament of Anesthesiolog and Intensive cCre"
                }, 
                "investigator": [
                    {
                        "last_name": "Radoslaw Owczuk, Ph.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Tomasz Jasinski, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gda\u0144sk", 
                        "country": "Poland", 
                        "zip": "80-214"
                    }, 
                    "name": "Medical University of Gda\u0144sk - Departament of Anesthesiology and Intensive Care"
                }, 
                "investigator": [
                    {
                        "last_name": "Radoslaw Owczuk, Ph.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Tomasz Jasinski, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Development of Procedures to Optimalize the Intensive Care Units Patients Clinical Condition. Evaluation of Influence of Nebulized Bronchodilatatory Drugs on Cardiac Repolarization", 
        "overall_contact": {
            "email": "tjasinski@uck.gda.pl", 
            "last_name": "Tomasz Jasinski, MD", 
            "phone": "0048-058-349-32-82"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: The Central Register of Clinical Trials"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes of electrophysiological parameters after nebulized bronchodilatator", 
            "safety_issue": "No", 
            "time_frame": "one hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01714401"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Gdansk", 
            "investigator_full_name": "Radoslaw Owczuk", 
            "investigator_title": "associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Medical University of Gdansk", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Gdansk", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}